DeepTrait
NGS Data Analysis Platform for Drug Discovery
Co-founded and built an AI-powered NGS data analysis platform that enables lab scientists to discover novel therapeutic targets and diagnostic markers in under six hours — with no coding, scripts, or command lines required.
The Challenge
Next-generation sequencing (NGS) data analysis required bioinformaticians with advanced programming skills. Lab scientists had to wait days for results and had no way to independently explore genomic datasets, run statistical tests, or annotate variants — creating critical bottlenecks in pre-clinical drug discovery pipelines.
Our Solution
We built DeepTrait — a no-code NGS data analysis platform designed by lab scientists, for lab scientists. The platform supports Kolmogorov-Smirnov statistical tests, ROC curve analysis, seamless variant and gene annotation across all major databases, and discovery of genetically supported therapeutic targets and diagnostic markers. Scientists go from raw data to actionable insights in under six hours.
The Impact
- Reduced NGS data analysis time from days to under 6 hours
- Eliminated dependency on bioinformaticians for routine analyses
- Enabled discovery of novel therapeutic targets and diagnostic markers
- Supported all major variant and gene annotation databases
Technologies Used
"DeepTrait fundamentally changed how our lab scientists interact with genomic data."
Dr. Ruslana Radchuk
Co-founder & Chief Biologist, DeepTrait
Related Case Studies
AstraZeneca
AI Product for Medical Affairs
Developed an AI insights analytics tool and insurance flow pipeline for a global pharmaceutical company, automating CRM record analysis to deliver actionable insights from large-scale Medical Affairs operations.
xFusion Technologies
RAG Chatbot for Enterprise Data Platform
Engineered an advanced Retrieval-Augmented Generation (RAG) system for xFusion's xAQUA® platform, enabling natural language querying across enterprise document repositories.
Ready to achieve similar results?
Every engagement begins with a conversation. Let's discuss how AI can drive outcomes for your organization.